PSORIATIC ARTHRITIS (PSA)
Clinical trials for PSORIATIC ARTHRITIS (PSA) explained in plain language.
Never miss a new study
Get alerted when new PSORIATIC ARTHRITIS (PSA) trials appear
Sign up with your email to follow new studies for PSORIATIC ARTHRITIS (PSA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to tame stubborn psoriatic arthritis
Disease control Not yet recruitingThis study tests whether adding deucravacitinib to standard therapy helps adults with psoriatic arthritis that is not well controlled. About 128 participants will receive the combination and be monitored for 48 weeks. The goal is to reduce skin and joint symptoms and improve qual…
Matched conditions: PSORIATIC ARTHRITIS (PSA)
Phase: PHASE4 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Arthritis app aims to boost drug safety skills
Knowledge-focused Not yet recruitingThis study tests whether a smartphone app can help people with rheumatoid arthritis, spondyloarthritis, or psoriatic arthritis learn how to use their anti-rheumatic drugs more safely. About 144 adults will either use the app or receive standard care with a website. The goal is to…
Matched conditions: PSORIATIC ARTHRITIS (PSA)
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
New blood test could spot autoimmune diseases earlier
Knowledge-focused Not yet recruitingThis study will use a special blood test called mass spectrometry to look at immune cells in 500 people with various autoimmune diseases and healthy volunteers. The goal is to find patterns that could help doctors diagnose these conditions sooner. No treatments are being tested; …
Matched conditions: PSORIATIC ARTHRITIS (PSA)
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC